Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eli Silvert

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Trials (London, England)|March 28, 2026
A randomized control trial of re-designed and shorter research informed consent forms to improve comprehensionEzekiel J Emanuel, Samantha Lopez-Rico, Merjan Lijerón Ozisik, et al.
Pulmonary Circulation|December 18, 2025
Assessing the Impact of Time to Diagnosis and Treatment for Patients With Pulmonary Arterial HypertensionHilary M DuBrock, Eli Silvert, Deeksha Doddahonnaiah, et al.
Molecular Genetics and Metabolism|September 14, 2023
Retrospective study of propionic acidemia using natural language processing in Mayo Clinic electronic health record dataHannah Barman, Vanja Sikirica, Katherine Carlson, et al.
Health Services Research|March 5, 2026
A Machine Learning Model to Improve Risk Adjustment Accuracy in MedicareDaniel K Shenfeld, Lindsay Warrenburg, Eli Silvert, et al.
American Journal of Hematology|July 5, 2023
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry dataEli Silvert, Laura Hester, Eshwan Ramudu, et al.
PNAS Nexus|July 21, 2022
SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomesColin Pawlowski, Eli Silvert, John C O'Horo, et al.
JCO Clinical Cancer Informatics|April 30, 2024
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language ProcessingHannah Barman, Sriram Venkateswaran, Antonio Del Santo, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalenceArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.
NPJ Systems Biology and Applications|November 28, 2024
A deep learning approach predicting the activity of COVID-19 therapeutics and vaccines against emerging variantsRobert P Matson, Isin Y Comba, Eli Silvert, et al.
Med (New York, N.Y.)|December 20, 2021
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infectionArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Trials (London, England)|March 28, 2026
A randomized control trial of re-designed and shorter research informed consent forms to improve comprehensionEzekiel J Emanuel, Samantha Lopez-Rico, Merjan Lijerón Ozisik, et al.
Pulmonary Circulation|December 18, 2025
Assessing the Impact of Time to Diagnosis and Treatment for Patients With Pulmonary Arterial HypertensionHilary M DuBrock, Eli Silvert, Deeksha Doddahonnaiah, et al.
Molecular Genetics and Metabolism|September 14, 2023
Retrospective study of propionic acidemia using natural language processing in Mayo Clinic electronic health record dataHannah Barman, Vanja Sikirica, Katherine Carlson, et al.
Health Services Research|March 5, 2026
A Machine Learning Model to Improve Risk Adjustment Accuracy in MedicareDaniel K Shenfeld, Lindsay Warrenburg, Eli Silvert, et al.
American Journal of Hematology|July 5, 2023
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry dataEli Silvert, Laura Hester, Eshwan Ramudu, et al.
PNAS Nexus|July 21, 2022
SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomesColin Pawlowski, Eli Silvert, John C O'Horo, et al.
JCO Clinical Cancer Informatics|April 30, 2024
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language ProcessingHannah Barman, Sriram Venkateswaran, Antonio Del Santo, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalenceArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.
NPJ Systems Biology and Applications|November 28, 2024
A deep learning approach predicting the activity of COVID-19 therapeutics and vaccines against emerging variantsRobert P Matson, Isin Y Comba, Eli Silvert, et al.
Med (New York, N.Y.)|December 20, 2021
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infectionArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.
Pageof 2